MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000548862

Медицинская библиотека · Respiration; international review of thoracic diseases · 2025

Drug-Induced Interstitial Lung Disease in Lung Cancer Patients.

Vanhandsaeme Gilles, Viskens Karolien, Van Ballaer Valerie, De Wever Walter, Defraene Gilles, Lambrecht Maarten, Donders Elena, Van Mol Pierre, Wauters Els

СтатьяОбзорПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

<p>

Background

Pulmonary toxicity is a possible adverse event (AE) of all systemic treatments for lung cancer. Drug-induced parenchymal and interstitial lung disease (D-ILD) is a rare but potentially life-threatening pulmonary AE. Its clinical and radiological manifestations are highly variable and nonspecific, making recognition and diagnosis particularly challenging. Summary: Effective management of D-ILD requires a high degree of clinical suspicion, supported by education of both patients and healthcare providers. Any lung cancer patient who develops new respiratory symptoms and/or new radiographic abnormalities should be promptly evaluated for possible D-ILD. However, the differential diagnosis is broad, including both infectious and noninfectious etiologies. Clinical, laboratory, microbial, and imaging findings should be incorporated to adjudicate the possibility of D-ILD. Given the absence of a definitive diagnostic test, D-ILD remains a complex diagnosis of exclusion that benefits from a multidisciplinary approach. Pulmonologists play an active role in an integrated diagnostic work-up and management of D-ILD, and they should therefore remain actively engaged in this clinically relevant subject. Key Messages: This review discusses the incidence, risk factors, clinical and radiographic features, and management strategies for D-ILD in the context of current systemic treatments for lung cancer. A practical framework for differential diagnosis is also provided to support clinical decision-making. </p>.

Для цитирования: Vanhandsaeme Gilles, Viskens Karolien, Van Ballaer Valerie, De Wever Walter, Defraene Gilles, Lambrecht Maarten, Donders Elena, Van Mol Pierre, Wauters Els. Drug-Induced Interstitial Lung Disease in Lung Cancer Patients.. Respiration; international review of thoracic diseases. 2025. DOI: 10.1159/000548862.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.